Evaluate the PK of LY03010 Process 1 and Process 2 Drug Product vs INVEGA SUSTENNA After Intramuscular Injection in Schizophrenia Patients
Condition(s):Schizophrenia PatientsLast Updated:November 9, 2020Completed
Hide Studies Not Open or Pending
Condition(s):Schizophrenia PatientsLast Updated:November 9, 2020Completed
Condition(s):Schizophrenia; Psychotic Disorders; Mood Disorders; Schizophrenia Spectrum; Mental Disorders; Antipsychotic Agents; Tranquilizing Agents; Central Nervous System Depressants; Physiological Effects of Drugs; Psychotropic Drugs; Neurotransmitter Agents; Molecular Mechanisms of Pharmacological ActionLast Updated:April 25, 2023Completed
Condition(s):SchizophreniaLast Updated:April 9, 2019Completed
Condition(s):Bipolar DisorderLast Updated:November 21, 2014Withdrawn
Condition(s):Schizophrenia; Schizoaffective DisorderLast Updated:November 23, 2015Unknown status
Condition(s):Schizo Affective Disorder; Schizophrenia; Schizoaffective DisorderLast Updated:August 13, 2019Completed
Condition(s):SchizophreniaLast Updated:October 28, 2010Unknown status
Condition(s):SchizophrenicsLast Updated:February 15, 2021Completed
Condition(s):Schizophrenia; Schizoaffective DisorderLast Updated:March 3, 2014Completed
Condition(s):SchizophreniaLast Updated:August 1, 2014Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.